Insulin Glargine (U-100) Cartridge Systems and Pens and Skyrizi topical
Determining the interaction of Insulin Glargine (U-100) Cartridge Systems and Pens and Skyrizi topical and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: risankizumab
Brand name: Skyrizi
Synonyms: Skyrizi
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Cartridge Systems and Pens-Sleep Aid
- Insulin Glargine (U-100) Cartridge Systems and Pens-Sleep Aid Tablets
- Insulin Glargine (U-100) Cartridge Systems and Pens-Sleepinal
- Insulin Glargine (U-100) Cartridge Systems and Pens-Slo-Niacin
- Insulin Glargine (U-100) Cartridge Systems and Pens-Slow Fe
- Insulin Glargine (U-100) Cartridge Systems and Pens-Slow Release Iron
- Skyrizi topical-Insulin Glargine (U-100) Vials
- Skyrizi topical-Insulin Glargine (U-300) Pens
- Skyrizi topical-Insulin glargine and lixisenatide
- Skyrizi topical-Insulin glargine and lixisenatide Subcutaneous
- Skyrizi topical-Insulin glargine, recombinant Subcutaneous
- Skyrizi topical-Insulin glulisine